Venture capital funds Innova/7, Booster Capital, GapMinder II and Morphosis Capital II are to receive up to EUR80 million investments from the National Recovery and Resilience Plan (NRRP) to fund at least thirty companies in development, as well as technology, manufacturing FMCG, B2B and B2C services and healthcare startups.